文献速递头颈部肿瘤放疗

HPV阳性口咽癌IMRT后局部区域复发中靶区勾画不足的空间分析

Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer.
PubMed 文献 · Radiother Oncol · 2017-05-13

该研究对50例HPV阳性口咽癌患者放疗后局部区域复发病灶进行空间分析,将复发MRI和PET影像与原始IMRT计划CT形变配准,计算复发肿瘤体积所受剂量。基于PET定义,40%为野内复发、41%为边缘漏照、18%为真性漏照;基于MRI定义分别为45%、39%和17%。结论认为相当比例复发属地理性漏照,或可通过更细致的IMRT计划设计避免,对降剂量策略和靶区质量控制有重要意义。

要点

  • HPV阳性口咽癌IMRT后复发中约41%为边缘漏照、约18%为真性漏照(PET定义)。
  • 地理性漏照提示靶区勾画不足,可能通过更细致的IMRT计划设计避免。
  • 该发现对正在进行的降剂量策略有重要影响,强调治疗前靶区复核的质量保证。

核心结论

  • 相当比例的HPV阳性口咽癌局部区域复发为地理性漏照,可能通过更细致的IMRT计划设计避免。
  • 该发现对降剂量策略有重要影响,并强调IMRT开始前仔细复核靶区的质量保证的重要性。

研究设计与样本

  • 回顾性分析107例既往照射野内局部区域复发、考虑再程放疗患者的记录。
  • 选取其中HPV阳性且原发口咽癌者,获取原始IMRT计划,将复发时MRI和PET与治疗前计划CT形变配准。
  • 在轴位影像上识别复发肿瘤体积(Vrecur),计算其受照剂量并用剂量体积直方图分析。

主要发现

  • 共50例口咽癌患者的83个复发病灶为HPV阳性并符合纳入标准。

临床怎么用

  • IMRT开始前应仔细复核靶区体积,并建立稳健的质量保证流程以减少地理性漏照。
  • 对HPV阳性口咽癌考虑降剂量策略时,需关注靶区勾画不足可能导致复发风险。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To perform a spatial analysis of local-regional recurrences, in relation to quantitative dose distribution, among patients treated by intensity-modulated radiotherapy (IMRT) for human papillomavirus (HPV)-positive oropharyngeal cancer. METHODS AND MATERIALS: The records of 107 consecutive patients who presented for consideration of re-irradiation for local-regional recurrent disease occurring in a previously irradiated field were reviewed. The original IMRT plans were retrieved for those with HPV-positive disease originating from the oropharynx, and deformable image registration was used to fuse the magnetic resonance imaging (MRI) and positron emission tomography (PET) scans obtained at recurrence to the pre-treatment planning computed tomography (CT) dataset. The recurrent tumor volume (Vrecur) was subsequently identified on axial imaging, and the dose of radiation received by Vrecur was then calculated and analyzed using dose-volume histograms. RESULTS: A total of 83 recurrent lesions occurring in 50 oropharyngeal cancer patients were HPV-positive and met inclusion criteria. Using PET-defined Vrecur, thirty-three lesions were classified as in-field recurrences (40%), 35 were marginal misses (41%), and 15 were true misses (18%). Using the MRI-defined Vrecur, thirty-seven lesions were classified as in-field recurrences (45%), 32 were marginal misses (39%), and 14 were true misses (17%). CONCLUSION: A significant proportion of local-regional recurrences from HPV-positive oropharyngeal cancer represented geographical misses which possibly could have been prevented with more meticulous attention to IMRT planning. This finding has important implications with respect to ongoing attempts to de-escalate radiation dose for this disease. Our data highlight the importance of robust quality assurance with careful review of target volumes prior to the initiation of IMRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chen AM, Chin R, Beron P, et al. Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer. Radiother Oncol. 2017. PMID: 28511960. doi:10.1016/j.radonc.2017.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。